NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Oct. 24, 2016--
Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus
Medical Imaging, Inc. (“LMI”), today announced that it will be
presenting at the 25th Annual Credit Suisse Healthcare
Conference on Monday, November 7, 2016 in Scottsdale, Arizona. Mary Anne
Heino, President and Chief Executive Officer, and Jack Crowley, Chief
Financial Officer, will present in a session scheduled at 1:30 p.m.
To access a live webcast of the presentation, please visit the Investors
section of the Company’s website at www.lantheus.com.
A replay of the webcast will be available on the Company’s website for
30 days following the live presentation.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc.
(“LMI”), a global leader in the development, manufacture and
commercialization of innovative diagnostic imaging agents and products.
LMI provides a broad portfolio of products, which are primarily used for
the diagnosis of cardiovascular diseases. LMI’s key products include the
echocardiography contrast agent DEFINITY® Vial for
(Perflutren Lipid Microsphere) Injectable Suspension; TechneLite®
(Technetium Tc99m Generator), a technetium-based generator that provides
the essential medical isotope used in nuclear medicine procedures; and
Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent
used to evaluate pulmonary function and for imaging the lungs. The
Company is headquartered in North Billerica, Massachusetts with in
Puerto Rico and Canada. For more information, visit www.lantheus.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161024006336/en/
Source: Lantheus Holdings, Inc.
Lantheus Holdings, Inc.
Meara Murphy, 978-671-8508